Pharmacokinetics and tissue penetration of enoxacin.
The pharmacokinetics of the quinolone enoxacin were studied after a 600-mg oral dose was given to each of six male volunteers. The levels of the compound were measured in serum, blister fluid, and urine. Absorption was variable, with peak levels (mean, 3.7 micrograms/ml) being attained between 0.75 and 3.0 h (mean, 1.9 h). The serum elimination half-life was 6.2 h, and 71.6% of the drug was recovered in the urine by 48 h. Enoxacin penetrated blister fluid well, the mean percent penetration being 78.4%.
D000328:Adult; D000890:Anti-Infective Agents / Q000378:metabolism*; D001768:Blister / Q000378:metabolism; D015365:Enoxacin; D005110:Extracellular Space / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D008297:Male; D009287:Naphthyridines / Q000097:blood / Q000378:metabolism*
D000890:Anti-Infective Agents; D009287:Naphthyridines; D015365:Enoxacin